Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
AVAILABLE
NCT07531433
Post-Trial Access to ATH434 for Patients With Multiple System Atrophy
Sponsor: Alterity Therapeutics
View on ClinicalTrials.gov
Summary
This multicenter post-trial access program is designed to provide ATH434 orally BID to eligible patients who completed Phase 2 studies ATH434-201 or ATH434-202, and who may benefit from this treatment according to the evaluation by their treating physicians.
Key Details
Gender
All
Age Range
Any - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-04-15
Healthy Volunteers
Not specified
Conditions
Interventions
DRUG
ATH434
ATH434 tablets